Guardant Health, Inc.
GH
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$96.72
Price+0.49%
$0.47
1Y
Price
Market Cap
$12.008b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-31.0%
EBITDA Margin-35.0%
Net Profit Margin-17.3%
Free Cash Flow MarginRevenue
$902.569m
+22.1%
1y CAGR+26.2%
3y CAGR+24.7%
5y CAGREarnings
-$398.789m
+8.6%
1y CAGR+14.8%
3y CAGR-4.2%
5y CAGREPS
-$3.21
+9.8%
1y CAGR+20.0%
3y CAGR-2.2%
5y CAGRBook Value
-$354.473m
$1.277b
Assets$1.631b
Liabilities$1.300b
DebtDebt to Assets
101.8%
-3.7x
Debt to EBITDAFree Cash Flow
-$262.233m
+4.6%
1y CAGR+11.9%
3y CAGR-0.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company